Difference between revisions of "Callon2016"
ElliottHoey (talk | contribs) (Created page with "{{BibEntry |BibType=ARTICLE |Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach |Title=Which Clinicia...") |
AndreiKorbut (talk | contribs) m (AndreiKorbut moved page Callon2015 to Callon2016 without leaving a redirect) |
||
(One intermediate revision by the same user not shown) | |||
Line 2: | Line 2: | ||
|BibType=ARTICLE | |BibType=ARTICLE | ||
|Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach | |Author(s)=Wynne Callon; Somnath Saha; P. Todd Korthuis; Ira B. Wilson; Richard D. Moore; Jonathan Cohn; Mary Catherine Beach | ||
− | |Title=Which | + | |Title=Which clinician questions elicit accurate disclosure of antiretroviral non-adherence when talking to patients? |
− | |Tag(s)=EMCA; AIDS; medication; Adherence; Physician-Patient Relations; Counseling; Medical; | + | |Tag(s)=EMCA; AIDS; medication; Adherence; Physician-Patient Relations; Counseling; Medical; |
− | |Key= | + | |Key=Callon2016 |
− | |Year= | + | |Year=2016 |
+ | |Language=English | ||
|Journal=AIDS and Behavior | |Journal=AIDS and Behavior | ||
+ | |Volume=20 | ||
+ | |Number=5 | ||
+ | |Pages=1108–1115 | ||
|URL=http://link.springer.com/article/10.1007/s10461-015-1231-7 | |URL=http://link.springer.com/article/10.1007/s10461-015-1231-7 | ||
|DOI=10.1007/s10461-015-1231-7 | |DOI=10.1007/s10461-015-1231-7 | ||
|Abstract=This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses. | |Abstract=This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses. | ||
− | |||
}} | }} |
Latest revision as of 10:40, 16 December 2019
Callon2016 | |
---|---|
BibType | ARTICLE |
Key | Callon2016 |
Author(s) | Wynne Callon, Somnath Saha, P. Todd Korthuis, Ira B. Wilson, Richard D. Moore, Jonathan Cohn, Mary Catherine Beach |
Title | Which clinician questions elicit accurate disclosure of antiretroviral non-adherence when talking to patients? |
Editor(s) | |
Tag(s) | EMCA, AIDS, medication, Adherence, Physician-Patient Relations, Counseling, Medical |
Publisher | |
Year | 2016 |
Language | English |
City | |
Month | |
Journal | AIDS and Behavior |
Volume | 20 |
Number | 5 |
Pages | 1108–1115 |
URL | Link |
DOI | 10.1007/s10461-015-1231-7 |
ISBN | |
Organization | |
Institution | |
School | |
Type | |
Edition | |
Series | |
Howpublished | |
Book title | |
Chapter |
Abstract
This study evaluated how clinicians assess antiretroviral (ARV) adherence in clinical encounters, and which questions elicit accurate responses. We conducted conversation analysis of audio-recorded encounters between 34 providers and 58 patients reporting ARV non-adherence in post-encounter interviews. Among 42 visits where adherence status was unknown by providers, 4 providers did not discuss ARVs (10 %), 6 discussed ARVs but did not elicit non-adherence disclosure (14 %), and 32 discussed ARVs which prompted disclosure (76 %). Questions were classified as: (1) clarification of medication (“Are you still taking the Combivir?”); (2) broad (“How’s it going with your meds?”); (3) positively-framed (“Are you taking your medications regularly?”); (4) negatively-framed (“Have you missed any doses?”). Clinicians asked 75 ARV-related questions: 23 clarification, 12 broad, 17 positively-framed, and 23 negatively-framed. Negatively-framed questions were 3.8 times more likely to elicit accurate disclosure than all other question types (p < 0.0001). Providers can improve disclosure probability by asking directly about missed doses.
Notes